DCJClass I
Beta-Globulin, Antigen, Antiserum, Control
21 CFR 866.5160 / Immunology
DCJ is the FDA product code for Beta-Globulin, Antigen, Antiserum, Control, a class I device type, regulated under 21 CFR 866.5160. As of , FDA records hold one 510(k) clearance under this code, the most recent dated , and no recalls.
Classification record
- Product code
- DCJ
- Device name
- Beta-Globulin, Antigen, Antiserum, Control
- Regulation
- 21 CFR 866.5160
- Device class
- Class I
- Review panel
- Immunology
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 1
- Ingested recalls
- 0
Clearances, product code DCJ
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1989 | 1 |
Applicants with the most clearances
Product code DCJ| Applicant | Clearances |
|---|---|
| E.I. Dupont de Nemours & Co., Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeNo registered establishment in MDM’s records lists product code DCJ.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
